We are live on
!
Find out more
ECP
Empyrean Capital Partners Portfolio holdings
AUM
$3.07B
1-Year Est. Return
34.24%
This Fund
S&P 500
This Quarter
Est. Return
+18.67%
1 Year Est. Return
+34.24%
3 Year Est. Return
+104.05%
5 Year Est. Return
+133.06%
10 Year Est. Return
+500.1%
AUM
$3.16B
AUM Growth
+$1.29B
(+69%)
Cap. Flow
+$905M
Cap. Flow
% of AUM
28.69%
Top 10 Holdings %
Top 10 Hldgs %
54.05%
Holding
89
New
25
Increased
13
Reduced
14
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$135M |
| 2 |
SHPG
Shire pic
SHPG
|
+$82.3M |
| 3 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$79.1M |
| 4 |
Equitable Holdings
EQH
|
+$61.8M |
| 5 |
GSAH.U
GS Acquisition Holdings Corp. Units, each consisting of one share of Class A common stock and one-th
GSAH.U
|
+$35.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$182M |
| 2 |
HRG
HRG Group, Inc.
HRG
|
+$92.4M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$84.7M |
| 4 |
Pfizer
PFE
|
+$33.3M |
| 5 |
Xerox
XRX
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.66% |
| 2 | Technology | 8.15% |
| 3 | Communication Services | 7.48% |
| 4 | Healthcare | 6.5% |
| 5 | Real Estate | 4.55% |
Similar funds
MRCP
VBA
CAM
HCM
DCM
CLG
SAG
EP
Empyrean Capital Partners's Q2 2018 Portfolio in Review
As of Q2 2018, Empyrean Capital Partners held 89 positions worth $3.16B, up 69% from $1.87B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Empyrean Capital Partners deployed $905M of net new capital in Q2 2018, opening 25 new positions and adding to 13 existing holdings. Its largest new stake was Aetna Inc: 759,600 shares worth $139M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 11% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Pfizer, an estimated $33.3M trimmed.
- Empyrean Capital Partners's largest Q2 2018 buy was Aetna Inc: 759,600 shares worth $139M.
- Empyrean Capital Partners added most to NXP Semiconductors in Q2 2018, an estimated $31.1M increase.
- Empyrean Capital Partners's biggest Q2 2018 reduction was Pfizer, cutting an estimated $33.3M.
- Empyrean Capital Partners fully exited Time Warner Inc in Q2 2018, selling an estimated $182M.
- Empyrean Capital Partners's ten largest holdings make up 54% of its $3.16B portfolio in Q2 2018.
- Empyrean Capital Partners opened 25 new positions and closed 10 in Q2 2018.
- Empyrean Capital Partners's portfolio value rose 69% quarter-over-quarter to $3.16B.
Based on Empyrean Capital Partners's 13F filing for Q2 2018, filed 14 Aug 2018.